Day: April 7, 2023

Oncocyte Announces Publication of DetermaIO Results from AtezoTRIBE Study in Metastatic Colorectal Cancer

Staff April 7, 2023

IRVINE, Calif., April 07, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostic company, today announces the peer-reviewed...

Covis Statement on FDA Decision to Withdraw Approval of Makena®

Staff April 7, 2023

ZUG, Switzerland, April 07, 2023 (GLOBE NEWSWIRE) -- Following the U.S. Food and Drug Administration’s decision, Covis Pharma Group (“Covis”)...

Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024

Staff June 8, 2024

Seniors in Metro Vancouver Invited to Participate in a Clinical Trial Assessing a New Immunomodulator Designed to Restore Immune Function in the Elderly

Staff June 8, 2024

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

Staff June 8, 2024

Numinus Clarifies Disclosures

Staff June 7, 2024

Woodfords Family Services Media Notice of Information Security Incident

Staff June 7, 2024

error: Content is protected !!

Oncocyte Announces Publication of DetermaIO Results from AtezoTRIBE Study in Metastatic Colorectal Cancer

Covis Statement on FDA Decision to Withdraw Approval of Makena®

You may have missed

Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024

Seniors in Metro Vancouver Invited to Participate in a Clinical Trial Assessing a New Immunomodulator Designed to Restore Immune Function in the Elderly

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

Numinus Clarifies Disclosures

Woodfords Family Services Media Notice of Information Security Incident